Literature DB >> 71640

Disopyramide-induced intrahepatic cholestasis.

T Meinertz, K H Langer, W Kasper, H Just.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 71640     DOI： 10.1016/s0140-6736(77)90768-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  A case of intra-hepatic cholestasis after disopyramide therapy.

Authors:  M E Edmonds; A M Hayler
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

Review 3.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 4.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

5.  Acute cardiac failure and hepatic ischemia induced by disopyramide phosphate.

Authors:  S J Scheinman; D S Poll; S Wolfson
Journal:  Yale J Biol Med       Date:  1980 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.